KR101577083B1 - 골다공증을 예방 및 개선하기 위한 칼슘, 마그네슘, 아연, 및 비타민 ｄ3을 포함하는 배합물 - Google Patents

골다공증을 예방 및 개선하기 위한 칼슘, 마그네슘, 아연, 및 비타민 ｄ3을 포함하는 배합물 Download PDF

Info

Publication number
KR101577083B1
KR101577083B1 KR1020107015770A KR20107015770A KR101577083B1 KR 101577083 B1 KR101577083 B1 KR 101577083B1 KR 1020107015770 A KR1020107015770 A KR 1020107015770A KR 20107015770 A KR20107015770 A KR 20107015770A KR 101577083 B1 KR101577083 B1 KR 101577083B1
Authority
KR
South Korea
Prior art keywords
calcium
magnesium
zinc
solubility
vitamin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020107015770A
Other languages
English (en)
Korean (ko)
Other versions
KR20100107468A (ko
Inventor
윤 카우 탐
저 린
Original Assignee
뷰티 펄 그룹 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 뷰티 펄 그룹 리미티드 filed Critical 뷰티 펄 그룹 리미티드
Publication of KR20100107468A publication Critical patent/KR20100107468A/ko
Application granted granted Critical
Publication of KR101577083B1 publication Critical patent/KR101577083B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof containing fruit or vegetable juices
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A23L33/155—Vitamins A or D
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A23L33/165—Complexes or chelates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Inorganic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pediatric Medicine (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
KR1020107015770A 2008-01-28 2009-01-28 골다공증을 예방 및 개선하기 위한 칼슘, 마그네슘, 아연, 및 비타민 ｄ3을 포함하는 배합물 Active KR101577083B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2399708P 2008-01-28 2008-01-28
US61/023,997 2008-01-28

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020157022508A Division KR20150100960A (ko) 2008-01-28 2009-01-28 골다공증을 예방 및 개선하기 위한 칼슘, 마그네슘, 아연, 및 비타민 ｄ3을 포함하는 배합물

Publications (2)

Publication Number Publication Date
KR20100107468A KR20100107468A (ko) 2010-10-05
KR101577083B1 true KR101577083B1 (ko) 2015-12-11

Family

ID=40913349

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020157022508A Ceased KR20150100960A (ko) 2008-01-28 2009-01-28 골다공증을 예방 및 개선하기 위한 칼슘, 마그네슘, 아연, 및 비타민 ｄ3을 포함하는 배합물
KR1020107015770A Active KR101577083B1 (ko) 2008-01-28 2009-01-28 골다공증을 예방 및 개선하기 위한 칼슘, 마그네슘, 아연, 및 비타민 ｄ3을 포함하는 배합물

Family Applications Before (1)

Application Number Title Priority Date Filing Date
KR1020157022508A Ceased KR20150100960A (ko) 2008-01-28 2009-01-28 골다공증을 예방 및 개선하기 위한 칼슘, 마그네슘, 아연, 및 비타민 ｄ3을 포함하는 배합물

Country Status (9)

Country Link
US (4) US9308222B2 (enExample)
EP (2) EP2257300B1 (enExample)
JP (2) JP5419298B2 (enExample)
KR (2) KR20150100960A (enExample)
CN (2) CN102908623A (enExample)
AU (1) AU2010212456B2 (enExample)
CA (1) CA2712647C (enExample)
NZ (1) NZ585408A (enExample)
WO (1) WO2009095798A2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20250106550A (ko) 2024-01-03 2025-07-10 규 재 유 나노입자경의 탄산칼슘과 탄산마그네슘 제조방법 및 그 방법으로 제조된 골다공증 예방치료제

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2712647C (en) * 2008-01-28 2016-08-30 Beauty Pearl Group Limited Formulas comprising calcium, magnesium, zinc, and vitamin d3 for the prevention and amelioration of osteoporosis
IT1400231B1 (it) * 2010-05-07 2013-05-24 Pharmanutra S R L Effetti dell' associazione di vitamina k2 e vitamina d3 nel consolidamento di una frattura ossea.
ITMI20110771A1 (it) * 2011-05-06 2012-11-07 Pharmanutra S R L Composizione comprendente una associazione di vitamine per uso nel trattamento della algodistrofia.
AU2012288401B9 (en) * 2011-07-27 2015-01-29 Sinoveda Canada, Inc. Formulas comprising highly soluble elements and vitamin for the prevention and amelioration of osteoporosis
CN103796658A (zh) * 2011-07-28 2014-05-14 加拿大生维达有限公司 含有高溶性元素和维生素并能预防和改善骨质疏松症的组合物
CN103416684A (zh) * 2013-08-05 2013-12-04 买世禄 改善骨质增生和关节疼痛的氨基酸结合多种微量元素的保健食品的生产方法
WO2019027428A1 (en) * 2017-07-31 2019-02-07 Avalon Bone Supplement (Hk) Limited MULTI-MINERAL COMPLEMENT FOR ENHANCED BONE DENSITY
KR102230498B1 (ko) 2019-07-31 2021-03-22 보비씨엔이(주) 골다공증 치료용 수소흡장 칼슘 함유 조성물

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030190369A1 (en) 2002-04-09 2003-10-09 Lovett William E. Vitamin formulation for enhancing bone strength
US20050181069A1 (en) 2003-06-17 2005-08-18 Mccleary Edward L. Composition and method for modulating hydrogen ion physiology

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5075499A (en) 1988-11-21 1991-12-24 Board Of Regents, The University Of Texas System Calcium supplementation by dicalcium citrate-lactate
CN1027419C (zh) 1990-08-08 1995-01-18 李久成 醋酸钙的制备方法及用途
TW403660B (en) 1992-07-13 2000-09-01 Shiseido Corp External skin treatment composition
CN1082836A (zh) * 1993-04-07 1994-03-02 苑德仲 制取钙质食品强化剂的方法
CN1039196C (zh) * 1993-05-28 1998-07-22 李晓焰 从珍珠、贝壳、珊瑚中提取保健钙剂的方法
US6716454B2 (en) 1994-09-23 2004-04-06 Laboratorie Innothera, Société Anonyme Therapeutic combination of vitamin and calcium in unitary galenic tablet form, a method of obtaining it, and the use thereof
IL115241A (en) 1994-09-26 2000-08-31 American Cyanamid Co Calcium dietary supplement
US5514382A (en) 1994-10-17 1996-05-07 Sultenfuss; Sherry Daily vitamin and mineral supplement for women
JP3438447B2 (ja) * 1994-12-28 2003-08-18 セイコーエプソン株式会社 テープ状記録媒体の印刷装置および印刷方法並びにテープ状記録媒体
US5698222A (en) 1995-04-07 1997-12-16 Abbott Laboratories Calcium supplement
JPH1014535A (ja) 1996-07-05 1998-01-20 Karunaa:Kk 飲食品用カルシウム剤
US5654011A (en) 1996-07-30 1997-08-05 Energetics, Inc. Dietary supplements
US6376549B1 (en) * 1998-09-17 2002-04-23 Akesis Pharmaceuticals, Inc. Metforimin-containing compositions for the treatment of diabetes
US6447809B1 (en) 1999-05-11 2002-09-10 Metagenics, Inc. Composition for promoting healthy bone structure
CN1117561C (zh) 1999-07-26 2003-08-13 李久成 复合钙制剂及其制备方法和用途
US6790462B2 (en) 2001-08-09 2004-09-14 Rhodia Inc. Calcium dietary supplement
US20050215493A1 (en) 2002-05-01 2005-09-29 Masaki Miyake Calcium-containing tissue strengthening agents and use thereof
CN1221268C (zh) 2002-10-11 2005-10-05 兰为民 镁钙离子复合制剂及其生产工艺
US20050053673A1 (en) * 2003-09-05 2005-03-10 Shrirang Netke Composition and method for facilitating bone healing
US8075910B2 (en) 2004-05-20 2011-12-13 Pbm Pharmaceuticals, Inc. Oral compositions comprising edible oils and vitamins and/or minerals and methods for making oral compositions
TW200640479A (en) 2005-05-30 2006-12-01 Pin-Hong Li Composition of Chinese medicine
TW200711648A (en) 2005-09-22 2007-04-01 Ching-Shun Wu Vitamins, minerals and regiment of plants for autonomic nervous system (including the vagus nerve) disorder or obstacle
BRPI0620210A2 (pt) * 2005-12-20 2011-11-01 Alcon Res Ltd composição e processos para a inibição da progressão da degeneração macular e para promover visão saudável
ITRM20060204A1 (it) 2006-04-10 2007-10-11 Vincenzo Savica Farmaci e alimentei per diete normoproteiche iperproteiche ipopro teiche tutte ipofosforiche e bevande ipofosforiche
JP2008013469A (ja) 2006-07-05 2008-01-24 Takeshi Ogura 海洋ミネラル成分からなる骨粗鬆症治療および／または予防剤
HU227610B1 (en) 2006-09-18 2011-09-28 Richter Gedeon Nyrt Pharmaceutical compositions containing rosuvastatin potassium
CA2712647C (en) 2008-01-28 2016-08-30 Beauty Pearl Group Limited Formulas comprising calcium, magnesium, zinc, and vitamin d3 for the prevention and amelioration of osteoporosis
TWI516279B (zh) 2010-07-28 2016-01-11 布爾頓國際集團有限公司 預防和改善骨質疏鬆症之含有高可溶性元素及維生素的調配物
AU2012288401B9 (en) 2011-07-27 2015-01-29 Sinoveda Canada, Inc. Formulas comprising highly soluble elements and vitamin for the prevention and amelioration of osteoporosis

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030190369A1 (en) 2002-04-09 2003-10-09 Lovett William E. Vitamin formulation for enhancing bone strength
US20050181069A1 (en) 2003-06-17 2005-08-18 Mccleary Edward L. Composition and method for modulating hydrogen ion physiology

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20250106550A (ko) 2024-01-03 2025-07-10 규 재 유 나노입자경의 탄산칼슘과 탄산마그네슘 제조방법 및 그 방법으로 제조된 골다공증 예방치료제

Also Published As

Publication number Publication date
JP2011510922A (ja) 2011-04-07
AU2010212456B2 (en) 2013-08-22
JP2014076995A (ja) 2014-05-01
US20100292194A1 (en) 2010-11-18
CA2712647C (en) 2016-08-30
EP2257300B1 (en) 2014-08-27
US9308222B2 (en) 2016-04-12
WO2009095798A2 (en) 2009-08-06
AU2010212456A1 (en) 2010-09-09
NZ585408A (en) 2012-06-29
KR20100107468A (ko) 2010-10-05
WO2009095798A3 (en) 2009-10-15
EP2257300A4 (en) 2012-04-18
US20140154332A1 (en) 2014-06-05
CA2712647A1 (en) 2009-08-06
EP2815751A1 (en) 2014-12-24
CN101925357B (zh) 2012-12-12
US20140342018A1 (en) 2014-11-20
US20110312923A1 (en) 2011-12-22
EP2257300A2 (en) 2010-12-08
KR20150100960A (ko) 2015-09-02
CN102908623A (zh) 2013-02-06
CN101925357A (zh) 2010-12-22
JP5419298B2 (ja) 2014-02-19
HK1149206A1 (en) 2011-09-30

Similar Documents

Publication Publication Date Title
KR101577083B1 (ko) 골다공증을 예방 및 개선하기 위한 칼슘, 마그네슘, 아연, 및 비타민 ｄ3을 포함하는 배합물
KR101325374B1 (ko) 신체 기능의 회복에 유용한 경구 또는 경장 조성물
US5128374A (en) Use of calcium citrate malate for the treatment of osteoporosis and related disorders
IE882609L (en) Methods for the treatment of osteoporosis and related disorders
Zhao et al. Acute versus chronic effects of whey proteins on calcium absorption in growing rats
AU2012288401B9 (en) Formulas comprising highly soluble elements and vitamin for the prevention and amelioration of osteoporosis
JP2005522485A (ja) 石灰化された動脈プラークの蓄積および細胞の機能不全を軽減し、イオンカルシウムの釣合いをとるための方法
CN103796658A (zh) 含有高溶性元素和维生素并能预防和改善骨质疏松症的组合物
HK1149206B (en) Formulas comprising calcium, magnesium, zinc, and vitamin d3 for the prevention and amelioration of osteoporosis
KR20240036285A (ko) 2-푸로산을 유효성분으로 포함하는 골 질환 및 뼈 건강 개선용 조성물
GB2507473A (en) A composition for enhancing the strength of bones
KR20170068147A (ko) 어린이의 골력과 치아의 발달을 보조하도록 구성되는 멸치 칼슘과 마그네슘, 아연 및 비타민d3를 포함하는 과립조성물
Khokhar et al. 19 Micronutrients
Brady et al. OsteoForce™
JP2006213627A (ja) 骨粗鬆症発症予防剤
CN103417520A (zh) 组合钙制剂
KR20050011987A (ko) 늙은 호박을 함유한 발효유 조성물

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20100716

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20131001

Comment text: Request for Examination of Application

AMND Amendment
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20141124

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20150622

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20141124

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

AMND Amendment
J201 Request for trial against refusal decision
PJ0201 Trial against decision of rejection

Patent event date: 20150721

Comment text: Request for Trial against Decision on Refusal

Patent event code: PJ02012R01D

Patent event date: 20150622

Comment text: Decision to Refuse Application

Patent event code: PJ02011S01I

Appeal kind category: Appeal against decision to decline refusal

Appeal identifier: 2015101004116

Request date: 20150721

A107 Divisional application of patent
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20150820

PB0901 Examination by re-examination before a trial

Comment text: Amendment to Specification, etc.

Patent event date: 20150721

Patent event code: PB09011R02I

Comment text: Request for Trial against Decision on Refusal

Patent event date: 20150721

Patent event code: PB09011R01I

Comment text: Amendment to Specification, etc.

Patent event date: 20150126

Patent event code: PB09011R02I

Comment text: Amendment to Specification, etc.

Patent event date: 20131004

Patent event code: PB09011R02I

B701 Decision to grant
PB0701 Decision of registration after re-examination before a trial

Patent event date: 20150910

Comment text: Decision to Grant Registration

Patent event code: PB07012S01D

Patent event date: 20150821

Comment text: Transfer of Trial File for Re-examination before a Trial

Patent event code: PB07011S01I

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20151207

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20151207

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
FPAY Annual fee payment

Payment date: 20181113

Year of fee payment: 4

PR1001 Payment of annual fee

Payment date: 20181113

Start annual number: 4

End annual number: 4

FPAY Annual fee payment

Payment date: 20191205

Year of fee payment: 5

PR1001 Payment of annual fee

Payment date: 20191205

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20201202

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 20211201

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 20221207

Start annual number: 8

End annual number: 8

PR1001 Payment of annual fee

Payment date: 20231206

Start annual number: 9

End annual number: 9